An anti-cancer compound developed at USA Health Mitchell Cancer Institute is showing promise in pre-clinical studies – one involving pancreatic cancer and the other involving breast cancer. The compound, MCI-715, was developed by Gary Piazza, Ph.D., and his lab team at the Drug Discovery Research Center at MCI.
About Cardiac Catheterization Lab
At the Cardiac Catheterization Lab, we provide diagnostic and interventional services for patients who suffer from symptoms of peripheral arterial disease (PAD).
The Cardiac Catheterization Lab hours of operation are Monday–Friday, 7:30 a.m.–4 p.m.